405939-39-1

Basic information

• Product Name: N-BOC-2-AMINO-5-BROMOTHIAZOLE
• Synonyms: tert-butyl N-(5-broMo-1,3-thiazol-2-yl)carbaMate;TERT-BUTYL (5-BROMO-1,3-THIAZOL-2-YL)CARBAMATE;TERT-BUTYL 5-BROMOTHIAZOL-2-YLCARBAMATE;N-BOC-2-AMINO-5-BROMOTHIAZOLE;N-Boc-2-Amino-5-bromothiazole95%;(5-BroMo-thiazol-2-yl)-carbaMic acid tert-butyl ester;2-(Boc-aMino)-5-broMothiazole
• CAS NO: 405939-39-1
• Molecular Formula: C₈H₁₁BrN₂O₂S
• Molecular Weight: 279.15414
• Product Categories: Thiazole;API intermediates
• Mol File: 405939-39-1.mol
• Article Data: 30

Chemical Properties

• Appearance: /Solid
• Density: 1.574 g/cm³
• Refractive Index: 1.596
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 4.58±0.70(Predicted)
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: N-BOC-2-AMINO-5-BROMOTHIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: N-BOC-2-AMINO-5-BROMOTHIAZOLE(405939-39-1)
• EPA Substance Registry System: N-BOC-2-AMINO-5-BROMOTHIAZOLE(405939-39-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 405939-39-1(Hazardous Substances Data)

Usage

General Description

N-BOC-2-amino-5-bromothiazole is a chemical compound with the molecular formula C10H12BrN3OS. It is a derivative of 2-amino-5-bromothiazole and contains a BOC (tert-butyloxycarbonyl) protecting group on the amino group. N-BOC-2-AMINO-5-BROMOTHIAZOLE has potential use in the synthesis of pharmaceuticals and agrochemicals due to its unique structure and reactivity. It is also used as a building block in organic synthesis and medicinal chemistry research. N-BOC-2-amino-5-bromothiazole is a valuable chemical that has many applications in the field of chemistry and biochemistry.

InChI:InChI=1/C8H11BrN2O2S/c1-8(2,3)13-7(12)11-6-10-4-5(9)14-6/h4H,1-3H3,(H,10,11,12)

Upstream product

• 3034-22-8 5-bromo-2-aminothiazole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 170961-15-6 tert-butyl 1,3-thiazole-2-yl-carbamate 
• 61296-22-8 5-bromothiazol-2-amine hydrobromide 
• 957346-62-2 5-bromo-1,3-thiazole-2-carboxylic acid 
• 75-65-0 tert-butyl alcohol 
• 4248-19-5 tert-butyl carbazate 

Downstream Products

• 881402-27-3 tert-butyl (5-bromothiazol-2-yl)(4-methoxybenzyl)carbamate 
• 405939-42-6 [6-(2-{tert-butoxycarbonyl-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-amino}-thiazol-5-yl)-pyrazin-2-yl]-(3-chloro-phenyl)-carbamic acid tert-butyl ester 
• 944804-88-0 tert-butyl N-(4-bromo-1,3-thiazol-2-yl)carbamate 
• 731018-54-5 2-(tert-butoxycarbonyl)amino-5-fluorothiazole 
• 957147-21-6 (5-trimethylsilanylethynyl-thiazol-2-yl)-carbamic acid tert-butyl ester 
• 1081314-08-0 tert-butyl-{5-[hydroxy(3-trifluoromethylphenyl)methyl]thiazol-2-yl}carbamate 
• 944804-72-2 (S)-tert-butyl 1-(N-(5-bromothiazol-2-yl)-tert-butoxycarbonylamino)-3-(4-(trifluoromethyl)phenyl)propan-2-ylcarbamate 
• 1236031-15-4 tert-butyl (5-bromo-1,3-thiazol-2-yl)((2R,3S)-2-((tert-butoxycarbonyl)amino)-3-((tert-butyl(dimethyl)silyl)oxy)-3-(4-(trifluoromethyl)phenyl)propyl)carbamate 
• 1236030-15-1 1,1-dimethylethyl 5-bromo-1,3-thiazol-2-yl((2S)-3-(4-(1,1-difluoroethyl)phenyl)-2-((((1,1-dimethylethyl)oxy)carbonyl)amino)propyl)carbamate 
• 1236031-10-9 tert-butyl (5-bromo-1,3-thiazol-2-yl)((2R,3S)-2-((tert-butoxycarbonyl)amino)-3-((tert-butyl(dimethyl)silyl)oxy)-3-(4-(1,1-difluoroethyl)phenyl)propyl)carbamate 
• 1245647-27-1 (5-Vinyl-thiazol-2-yl)-carbamic acid tert-butyl ester 
• 944805-17-8 tert-butyl (4-bromo-5-formylthiazol-2-yl)carbamate 
• 1355249-32-9 C₂₅H₃₀N₄O₇S 
• 1355249-33-0 C₂₁H₂₆N₄O₅S 

Relevant articles and documents

Halogen-Dance-Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2-Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases

A series of acyclic nucleoside phosphonates (ANPs) was designed as inhibitors of bacterial adenylate cyclases (ACs), where adenine was replaced with 2-amino-4-arylthiazoles. The target compounds were prepared using the halogen dance reaction. Final AC inh

NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9

The present invention relates to an inhibitor of cyclin-dependent kinase CDK9, having a structure of formula (I). The present invention also provides a method of treating a cancer of a precancerous condition related to CDK9 activity with the inhibitor and a use of the same.

DIAZANAPHTHALEN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF

Diazanaphthalene compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of a diazanaphthalene compound or analogs thereof, in the treatment of disorders characterized by the activa